[Retracted] Effect of Thymosin on Inflammatory Factor Levels, Immune Function, and Quality of Life in Lung Cancer Patients Undergoing Radical Thoracoscopic Surgery

Table 4

Comparison of immune function ().

		Study group (n = 60)	Control group (n = 60)	t
CD4 (^+%)	Before	37.25 ± 9.26	35.37 ± 9.24	1.113	0.268
	After	34.19 ± 7.29	30.58 ± 7.86	2.608	0.010
CD8 (^+%)	Before	31.74 ± 9.57	31.21 ± 7.92	0.331	0.742
	After	28.58 ± 7.26	25.08 ± 7.95	2.518	0.013
CD4^+/CD8^+	Before	1.21 ± 0.29	1.17 ± 0.27	0.782	0.436
	After	1.11 ± 0.32	0.86 ± 0.21	5.059	<0.001
NK (%)	Before	24.52 ± 4.41	23.98 ± 4.08	0.696	0.488
	After	21.75 ± 4.18	18.12 ± 3.82	4.966	<0.001

compared with pretreatment.